Brendan gets $120k for making no sales. (Ignoring commissions) Yacov gets $240k if nasdaq lists regardless of Nasdaq performance after listing.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%